Primary Ovarian Insufficiency Support Protocol
Primary Stack
Core supplements with strongest evidenceCritical for bone health; POI increases osteoporosis risk; often deficient
Supporting Studies (1)
Essential for bone health; estrogen deficiency accelerates bone loss
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsMay support ovarian function and improve fertility outcomes in some cases
Supporting Studies (1)
Supports mitochondrial function in oocytes; being studied for fertility
Supporting Studies (1)
Cardiovascular protection; estrogen deficiency increases CV risk
Supporting Studies (1)
Supports bone health; may help with mood and sleep disturbances
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Primary Ovarian Insufficiency (POI), previously called premature ovarian failure, occurs when the ovaries stop functioning normally before age 40. This leads to irregular periods, low estrogen, and often infertility.
KEY FEATURES:
CAUSES:
CRITICAL: POI requires medical management for hormone replacement and associated health risks. This protocol is SUPPORTIVE ONLY.
MEDICAL MANAGEMENT:
LONG-TERM HEALTH CONCERNS:
* Vitamin D and calcium are critical for bone health.
* DHEA may support ovarian function (discuss with specialist).
* Cardiovascular protection with omega-3 and healthy lifestyle.
Expected timeline: HRT provides immediate symptom relief. Bone and cardiovascular protection requires ongoing management. Supplements support overall health alongside HRT.
Clinical Perspective
Primary Ovarian Insufficiency: Cessation of ovarian function before 40. Diagnosis: elevated FSH (>25 IU/L x 2, 4-6 weeks apart), oligo/amenorrhea >4 months, age <40. Affects 1% of women. Causes: idiopathic (most), genetic (FMR1, Turner), autoimmune, iatrogenic.
CRITICAL: HRT (estrogen + progesterone) is standard of care until typical menopause age (~50) - reduces bone loss, CVD risk, vasomotor symptoms. Test: karyotype, FMR1, thyroid, adrenal antibodies. Fertility: spontaneous pregnancy 5-10%; egg donation most effective. Bone health: DEXA at diagnosis; calcium, vitamin D essential. DHEA controversial but some evidence for fertility. Supplements supportive only - do not replace HRT.
* Vitamin D (B-grade): Bone health. Review: (PMID: 28750270). 2000-4000 IU daily.
* Calcium (B-grade): Bone health. Guidelines: (PMID: 28332116). 1000-1200mg daily.
* DHEA (C-grade): Ovarian support. Systematic review: (PMID: 25111582). 25-75mg daily (supervised).
* CoQ10 (C-grade): Oocyte mitochondria. Review: (PMID: 24268541). 200-600mg daily.
* Omega-3 (B-grade): CV protection. Review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Magnesium (C-grade): Bone/mood. Review: (PMID: 28445426). 300-400mg daily.
Assessment targets: Hormone levels, bone density, lipid panel, symptom control, fertility status.
Protocol notes: HRT: essential; start at diagnosis; continue until age 50; reduces mortality. Estrogen: oral or transdermal; physiologic doses (not contraceptive doses). Progesterone: required if uterus present. Fertility: egg donation success rate ~50% per cycle; own eggs possible but low success. DHEA: if pursuing fertility, 6-16 weeks before IVF. Genetic testing: FMR1 (Fragile X) affects family counseling; karyotype if Turner suspected. Autoimmune: check thyroid, adrenal antibodies; may have other autoimmune conditions. Bone: DEXA at diagnosis; repeat q2-3 years. CV risk: lifestyle, lipids, BP monitoring. Psychological: significant emotional impact; counseling helpful. Support groups: POI-specific resources valuable.